A nurse in the antepartum unit is assisting with the care of a client who is at 36 weeks of gestation and reports continuous abdominal pain and dark red vaginal bleedinG. The tocodynamometer shows low amplitude high frequency uterine activity. The nurse should identify that the client is likely experiencing which of the following complications? (Select onE.:

Choice A: Administering saline drops into the newborn's nares is not the first action, as it can cause aspiration and irritation of the nasal mucosA. The nurse should clear the airway of the newborn before administering any medication or fluiD.

Choice B: Suctioning the newborn's mouth first and then the nose with a bulb syringe is the first and most important action, as it can remove the excess mucus and prevent obstruction and aspiration of the airway. The nurse should squeeze the bulb syringe before inserting it into the mouth or nose and release it gently to create suction. The nurse should suction the mouth before the nose to avoid pushing the mucus back into the throat.

Choice C: Placing the newborn in Trendelenburg position is not an appropriate action, as it can cause the mucus to flow back into the throat and lungs and increase the risk of aspiration and infection. The nurse should keep the newborn's head slightly lower than the chest to facilitate the drainage of the mucus.

Choice D: Performing deep suctioning of the newborn's trachea with an endotracheal tube is not an appropriate action, as it can cause trauma and inflammation of the trachea and vocal cords and increase the risk of bleeding and infection. The nurse should only perform this action if the newborn has signs of respiratory distress or meconium aspiration and under the supervision of a provider.

Choice A: Thromboembolic events are not prevented by methylergonovinE. Thromboembolic events are blood clots that can form in the veins or arteries and cause serious complications such as pulmonary embolism or strokE. Methylergonovine is a uterotonic agent that stimulates the contraction of the uterus and can actually increase the risk of thromboembolic events by causing vasoconstriction and hypertension.

Choice B: Postpartum hemorrhage is prevented by methylergonovinE. Postpartum hemorrhage is excessive bleeding after delivery that can result from uterine atony, retained placenta, or lacerations. Methylergonovine is a uterotonic agent that stimulates the contraction of the uterus and helps control the bleeding by compressing the blood vessels and expelling any placental fragments.

Choice C: Postpartum infection is not prevented by methylergonovinE. Postpartum infection is a bacterial infection that can affect the uterus, the vagina, the bladder, or the breast after delivery. Methylergonovine is a uterotonic agent that has no antibacterial activity and can actually increase the risk of infection by causing fever and chills.

Choice D: Hypertension is not prevented by methylergonovinE. Hypertension is high blood pressure that can cause complications such as preeclampsia, eclampsia, or strokE. Methylergonovine is a uterotonic agent that can actually cause or worsen hypertension by stimulating the alpha-adrenergic receptors and causing vasoconstriction.